Both in Pharmaceuticals
Cellectar Biosciences INC NEW vs BioVie
Over the past year CLRB returned −60.3% and BIVI returned +1.2%; their daily moves had a correlation of 0.12.
CLRB −60.3% BIVI +1.2%Growth of $1, one year, split-adjusted
| Metric | CLRB | BIVI |
|---|---|---|
| Price | $1.31 | $1.73 |
| Market cap | $12.4M | $15.0M |
| Today | +7.38% | +26.28% |
| 1 month | −21.6% | +20.1% |
| 6 months | −58.8% | +4.8% |
| Year to date | −55.6% | +49.1% |
| 1 year | −61.4% | −1.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.0M | $9.0M |
| Dividend yield | — | — |
| Volatility (60d) | 68.1% | 154.1% |
| Short % of float | 2.9% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).